Insider · CIK 0001207107
EBSWORTH DAVID R
Reports to the SEC for 2 companies · LONDON, X0
Transactions
35
Companies
2
Filings
5
CIK
0001207107
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-10-07 | VRNAVerona Pharma plcD Disposition to Issuer | — |
| 2025-10-07 | VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion | — |
| 2025-10-07 | VRNAVerona Pharma plcD Disposition to Issuer | — |
| 2025-10-07 | VRNAVerona Pharma plcM Exercise/Conversion | — |
| 2025-10-07 | VRNAVerona Pharma plcD Disposition to Issuer | — |
| 2025-08-01 | VRNAVerona Pharma plcM Exercise/Conversion | — |
| 2025-08-01 | VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-08-01 | VRNAVerona Pharma plcS Sale | −$25K |
| 2025-05-01 | VRNAVerona Pharma plcM Exercise/Conversion | +$271K |
| 2025-05-01 | VRNAVerona Pharma plc · Stock Option (Right to Exercise)M Exercise/Conversion | — |
| 2025-04-25 | VRNAVerona Pharma plc · Restricted Share UnitsA Award | — |
| 2025-02-26 | VRNAVerona Pharma plc · Share Option (Right to Exercise)M Exercise/Conversion | — |
| 2025-02-26 | VRNAVerona Pharma plcM Exercise/Conversion | +$49.6K |
| 2025-02-26 | VRNAVerona Pharma plcM Exercise/Conversion | +$101K |
| 2025-02-26 | VRNAVerona Pharma plcM Exercise/Conversion | +$256K |
| 2025-02-26 | VRNAVerona Pharma plcM Exercise/Conversion | +$193K |
| 2025-02-26 | VRNAVerona Pharma plcG Gift | — |
| 2025-02-26 | VRNAVerona Pharma plc · Share Option (Right to Exercise)M Exercise/Conversion | — |
| 2025-02-26 | VRNAVerona Pharma plc · Share Option (Right to Exercise)M Exercise/Conversion | — |
| 2025-02-26 | VRNAVerona Pharma plc · Share Option (Right to Exercise)M Exercise/Conversion | — |
| 2024-11-18 | VRNAVerona Pharma plcP Purchase | +$88.8K |
| 2024-11-06 | VRNAVerona Pharma plcP Purchase | +$189K |
| 2024-08-12 | VRNAVerona Pharma plcP Purchase | +$103K |
| 2024-04-29 | VRNAVerona Pharma plc · Share Options (Right to Buy)A Award | — |
| 2023-11-06 | VRNAVerona Pharma plcP Purchase | +$316K |
| 2023-04-28 | VRNAVerona Pharma plc · Share Options (Right to Buy)A Award | — |
| 2022-04-28 | VRNAVerona Pharma plc · Share Options (Right to Buy)A Award | — |
| 2021-08-09 | VRNAVerona Pharma plc · Share Options (Right to Buy)A Award | — |
| 2021-05-04 | VRNAVerona Pharma plcS Sale | −$9,391.205 |
| 2021-02-01 | VRNAVerona Pharma plcS Sale | −$11.8K |
| 2006-05-03 | CURAGEN CORPCommon Stock (Right to Buy)A Award | +$57.8K |
| 2006-05-03 | CURAGEN CORPCommon Stock (Right to Buy)A Award | +$9,625 |
| 2004-05-27 | CURAGEN CORPP Purchase | +$50K |
| 2004-05-26 | CURAGEN CORPStock Option (Right to Buy)A Award | +$66.8K |
| 2004-05-26 | CURAGEN CORPStock Option (Right to Buy)A Award | +$13.4K |
Recent filings
- 4EBSWORTH DAVID R0001104659-25-097951SEC(opens sec.gov)
- 4EBSWORTH DAVID R0001104659-25-074388SEC(opens sec.gov)
- 4EBSWORTH DAVID R0001104659-25-044534SEC(opens sec.gov)
- 4EBSWORTH DAVID R0001104659-25-041409SEC(opens sec.gov)
- 4EBSWORTH DAVID R0001104659-25-019171SEC(opens sec.gov)
Companies
Address
3 MORE LONDON RIVERSIDE
LONDON, X0, SE1 2RE